ESG

Traini's new generative AI collar claims to translate dog emotions into human language. But does the science back up this multi-million dollar bet?

Valens Semiconductor's 2024 ESG report details major drops in emissions and energy use, but how do these gains stack up in the high-stakes tech world?

As its partnership with Rio Tinto's Nuton ends, Arizona Sonoran will independently advance its massive copper project, betting on strong economics.

REE Automotive and BorgWarner's Cascadia Motion partner to create a revolutionary 'off-the-shelf' electric drive unit, accelerating the EV transition.

Greenwich LifeSciences execs extend their stock lock-up to 6 years, signaling massive confidence in their breast cancer drug showing an 80% recurrence drop.

A $10.5M investment gives Enduring Wealth Capital near-majority control of Cango, accelerating its pivot to AI and raising questions about its future.

Adlai Nortye licenses its promising pan-RAS cancer inhibitor to ASK Pharm for Greater China in a deal valued at up to $230 million.

From coal-heavy to fully green, ACEN has completed a landmark transition. Inside the strategy that made it an Asia-Pacific renewable energy leader.

High turnout and a peaceful vote mark CAR's election, but President Touadéra's quest for a third term raises questions about the nation's democratic future.

With a strong debut on the Hong Kong Stock Exchange, USAS Building System highlights growing investor faith in prefabricated industrial construction.

Diamyd Medical's pivotal Phase 3 trial gets a nine-month acceleration, raising hopes for a new precision therapy that preserves insulin production.

A major order for advanced semiconductor equipment will fuel a European firm's expansion, powering next-gen AI data centers and LiDAR systems.

As pharma moves beyond small molecules, a new integrated platform helps developers navigate the challenges of PROTACs, peptides, and antibody drugs.

Croatian firm Orqa is building a global network to produce one million drones annually, challenging market leaders and securing allied defense supply chains.

Tevogen's Dr. Ryan Saadi donates over $88,000 in company stock to a UN-recognized charity, bolstering educational programs for underserved children.

Fourth-generation farmer John Melo brings large-scale operational expertise to the Dairy Council, poised to shape California's dairy sustainability and health initiatives.

Chile's state oil firm, ENAP, sees massive investor demand for its debt buyback, a move that strengthens its balance sheet for a major energy transition.

Mirum raises over a quarter-billion dollars to acquire Bluejay Therapeutics, targeting a high-potential liver disease drug and signaling major growth.

A landmark executive order to reschedule cannabis and create a Medicare CBD program could unleash a $30B market and redefine the economics of the industry.

In a landmark deal, BioMarin acquires Amicus Therapeutics, gaining high-growth drugs and reshaping the landscape for patients with rare genetic disorders.